Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Multinuclear MRI at Ultrahigh Fields.

Niesporek SC, Nagel AM, Platt T.

Top Magn Reson Imaging. 2019 Jun;28(3):173-188. doi: 10.1097/RMR.0000000000000201.

PMID:
31188275
2.

Corrections of myocardial tissue sodium concentration measurements in human cardiac 23 Na MRI at 7 Tesla.

Lott J, Platt T, Niesporek SC, Paech D, G R Behl N, Niendorf T, Bachert P, Ladd ME, Nagel AM.

Magn Reson Med. 2019 Jul;82(1):159-173. doi: 10.1002/mrm.27703. Epub 2019 Mar 12.

PMID:
30859615
3.

Probing the microscopic environment of 23 Na ions in brain tissue by MRI: On the accuracy of different sampling schemes for the determination of rapid, biexponential T2* decay at low signal-to-noise ratio.

Lommen JM, Flassbeck S, Behl NGR, Niesporek S, Bachert P, Ladd ME, Nagel AM.

Magn Reson Med. 2018 Aug;80(2):571-584. doi: 10.1002/mrm.27059. Epub 2018 Jan 17.

PMID:
29344985
4.

Reproducibility of CMRO2 determination using dynamic 17 O MRI.

Niesporek SC, Umathum R, Lommen JM, Behl NGR, Paech D, Bachert P, Ladd ME, Nagel AM.

Magn Reson Med. 2018 Jun;79(6):2923-2934. doi: 10.1002/mrm.26952. Epub 2017 Oct 13.

PMID:
29030876
5.

Improved T*₂ determination in 23Na, 35Cl, and 17O MRI using iterative partial volume correction based on 1H MRI segmentation.

Niesporek SC, Umathum R, Fiedler TM, Bachert P, Ladd ME, Nagel AM.

MAGMA. 2017 Dec;30(6):519-536. doi: 10.1007/s10334-017-0623-2. Epub 2017 May 26.

PMID:
28550649
6.

Partial volume correction for in vivo (23)Na-MRI data of the human brain.

Niesporek SC, Hoffmann SH, Berger MC, Benkhedah N, Kujawa A, Bachert P, Nagel AM.

Neuroimage. 2015 May 15;112:353-363. doi: 10.1016/j.neuroimage.2015.03.025. Epub 2015 Mar 20.

PMID:
25797831
7.

Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O.

Mol Cancer. 2008 Sep 18;7:72. doi: 10.1186/1476-4598-7-72.

8.

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.

Weichert W, Röske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C.

Clin Cancer Res. 2008 Mar 15;14(6):1669-77. doi: 10.1158/1078-0432.CCR-07-0990.

9.

[NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].

Niesporek S, Weichert W, Sinn B, Röske A, Noske A, Buckendahl AC, Wirtz R, Sehouli J, Koensgen D, Dietel M, Denkert C.

Verh Dtsch Ges Pathol. 2007;91:243-9. German.

PMID:
18314621
10.

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.

Noske A, Weichert W, Niesporek S, Röske A, Buckendahl AC, Koch I, Sehouli J, Dietel M, Denkert C.

Cancer. 2008 Apr 15;112(8):1733-43. doi: 10.1002/cncr.23354.

11.

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.

Weichert W, Röske A, Gekeler V, Beckers T, Stephan C, Jung K, Fritzsche FR, Niesporek S, Denkert C, Dietel M, Kristiansen G.

Br J Cancer. 2008 Feb 12;98(3):604-10. doi: 10.1038/sj.bjc.6604199. Epub 2008 Jan 22.

12.

Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.

Niesporek S, Kristiansen G, Thoma A, Weichert W, Noske A, Buckendahl AC, Jung K, Stephan C, Dietel M, Denkert C.

Int J Oncol. 2008 Feb;32(2):341-7.

PMID:
18202756
13.

High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.

Weichert W, Boehm M, Gekeler V, Bahra M, Langrehr J, Neuhaus P, Denkert C, Imre G, Weller C, Hofmann HP, Niesporek S, Jacob J, Dietel M, Scheidereit C, Kristiansen G.

Br J Cancer. 2007 Aug 20;97(4):523-30. Epub 2007 Jul 10.

14.

Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer.

Chen Y, Pacyna-Gengelbach M, Deutschmann N, Niesporek S, Petersen I.

Int J Cancer. 2007 Sep 1;121(5):1021-7.

15.

Overexpression of cyclooxygenase-2 in human prostate carcinoma and prostatic intraepithelial neoplasia-association with increased expression of Polo-like kinase-1.

Denkert C, Thoma A, Niesporek S, Weichert W, Koch I, Noske A, Schicktanz H, Burkhardt M, Jung K, Dietel M, Kristiansen G.

Prostate. 2007 Mar 1;67(4):361-9.

PMID:
17265445
16.

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, Niesporek S, Könsgen D, Dietel M, Fiehn O.

Cancer Res. 2006 Nov 15;66(22):10795-804.

17.

Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.

Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M, Weichert W.

Mod Pathol. 2006 Sep;19(9):1261-9. Epub 2006 Jun 23.

18.

Expression patterns of polo-like kinase 1 in human gastric cancer.

Weichert W, Ullrich A, Schmidt M, Gekeler V, Noske A, Niesporek S, Buckendahl AC, Dietel M, Denkert C.

Cancer Sci. 2006 Apr;97(4):271-6.

19.

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.

Noske A, Kaszubiak A, Weichert W, Sers C, Niesporek S, Koch I, Schaefer B, Sehouli J, Dietel M, Lage H, Denkert C.

Cancer Lett. 2007 Feb 8;246(1-2):190-200. Epub 2006 Apr 3.

PMID:
16584837
20.

Extensive coronary thrombosis in thrombotic-thrombocytopenic purpura.

Hasper D, Schrage D, Niesporek S, Knollmann F, Barckow D, Oppert M.

Int J Cardiol. 2006 Jan 26;106(3):407-9.

PMID:
16337055
21.

Primary fibrosarcoma of the liver infiltrating the right atrium of the heart.

Kelle S, Paetsch I, Neuss M, Gebker R, Niesporek S, Meyer R, Fleck E, Nagel E.

Int J Cardiovasc Imaging. 2005 Dec;21(6):655-8.

PMID:
16322927
22.

Polo-like kinase 1 expression is a prognostic factor in human colon cancer.

Weichert W, Kristiansen G, Schmidt M, Gekeler V, Noske A, Niesporek S, Dietel M, Denkert C.

World J Gastroenterol. 2005 Sep 28;11(36):5644-50.

23.

Expression of lysophosphatidic acid acyltransferase beta (LPAAT-beta) in ovarian carcinoma: correlation with tumour grading and prognosis.

Niesporek S, Denkert C, Weichert W, Köbel M, Noske A, Sehouli J, Singer JW, Dietel M, Hauptmann S.

Br J Cancer. 2005 May 9;92(9):1729-36.

24.

Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.

Weichert W, Kristiansen G, Winzer KJ, Schmidt M, Gekeler V, Noske A, Müller BM, Niesporek S, Dietel M, Denkert C.

Virchows Arch. 2005 Apr;446(4):442-50. Epub 2005 Mar 23.

PMID:
15785925
26.

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.

Denkert C, Weichert W, Winzer KJ, Müller BM, Noske A, Niesporek S, Kristiansen G, Guski H, Dietel M, Hauptmann S.

Clin Cancer Res. 2004 Aug 15;10(16):5580-6.

Supplemental Content

Loading ...
Support Center